COMPARATIVE STUDY
EVALUATION STUDIES
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Evaluation of Bifenthrin and Deltamethrin Barrier Sprays for Mosquito Control in Eastern North Carolina.

Mosquitoes are a nuisance and potentially transmit pathogens causing numerous diseases worldwide. Homeowners and others may hire private companies to alleviate mosquito-related issues. Here, two pyrethroids (Suspend Polyzone [deltamethrin] and Bifen Insecticide/Termiticide [bifenthrin]) were evaluated on properties in North Carolina for 23 wk from 18 May through 19 October 2015. Properties were treated using backpack mist blowers every 21 d. At 17 fixed sampling locations, Centers for Disease Control and Prevention carbon dioxide-baited traps were deployed overnight once/week for the duration of the experiment. Oviposition traps were deployed weekly at the same locations. Differences were observed in mosquito abundance between neighborhoods, treatments, and weeks and differences varied between species. Mosquito abundance was generally significantly higher in traps placed on control properties (no insecticide) compared to traps placed on treatment properties. Bifenthrin and deltamethrin showed differences from each other in efficacy, but this varied between neighborhoods and species. Future studies could test the efficacy of barrier sprays at different application frequencies and/or in conjunction with weather monitoring. Coupled with regular mosquito surveillance and using integrated pest management principles, barrier sprays can be an effective tool for suppression of mosquito populations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app